• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Machine learning insights concerning inflammatory and liver-related risk comorbidities in noncommunicable and viral diseases

    2022-12-01 01:45:40AlfredoMartinezMartaAlonsoBernaldezDiegoMartinezUrbistondoJuanVargasNuiezAnaRamirezdeMolinaAlbertoDavalosOmarRamosLopez
    World Journal of Gastroenterology 2022年44期

    Alfredo Martinez,Marta Alonso-Bernaldez, Diego Martinez-Urbistondo, Juan A Vargas-Nuiez,Ana Ramirez de Molina,Alberto Davalos, Omar Ramos-Lopez

    Abstract The liver is a key organ involved in a wide range of functions, whose damage can lead to chronic liver disease (CLD). CLD accounts for more than two million deaths worldwide, becoming a social and economic burden for most countries.Among the different factors that can cause CLD, alcohol abuse, viruses, drug treatments, and unhealthy dietary patterns top the list. These conditions prompt and perpetuate an inflammatory environment and oxidative stress imbalance that favor the development of hepatic fibrogenesis. High stages of fibrosis can eventually lead to cirrhosis or hepatocellular carcinoma (HCC). Despite the advances achieved in this field, new approaches are needed for the prevention,diagnosis, treatment, and prognosis of CLD. In this context, the scientific community is using machine learning (ML) algorithms to integrate and process vast amounts of data with unprecedented performance. ML techniques allow the integration of anthropometric, genetic, clinical, biochemical, dietary, lifestyle and omics data, giving new insights to tackle CLD and bringing personalized medicine a step closer. This review summarizes the investigations where ML techniques have been applied to study new approaches that could be used in inflammatoryrelated, hepatitis viruses-induced, and coronavirus disease 2019-induced liver damage and enlighten the factors involved in CLD development.

    Key Words: Machine learning; Liver inflammation; Liver disease; Viral diseases; Comorbidity

    INTRODUCTION

    The liver is a key organ involved in relevant homeostatic metabolic and detoxifying human functions[1]. Thus, the liver is the epicenter of an organ-organ network weaving a series of complex interactions in the organism, which makes liver damage an underlying adverse condition in a whole set of diseases.Chronic liver disease (CLD) can be caused mainly by alcoholic liver-related dysfunctions, hepatitis B virus (HBV), hepatitis C virus (HCV), drug treatments, or non-alcoholic fatty liver disease (NAFLD), as recently updated to the term metabolic-associated FLD (Figure 1)[2,3]. Patients with liver-related diseases need frequent follow-ups and careful monitoring since CLD can eventually lead to cirrhosis or hepatocellular carcinoma (HCC) if not diagnosed on time for treatment or surgery. These CLD-related conditions have become a global burden, whose mortality associated rates have increased over the years reaching more than 2 million deaths worldwide[4].

    CLD is usually accompanied by an unhealthy inflammatory environment[5]. The immune response is a fundamental process to maintain homeostasis within the organism defense machinery and is characterized by the secretion of proinflammatory cytokines, like interleukin (IL)-1, tumor necrosis factor-α(TNF-α), and prostaglandin E2, in an acute manner in order to resolve sudden damage[5]. However, if sustained over time, these abnormal levels of inflammatory cytokines cause low-grade inflammation(LGI). LGI is a silent condition that predisposes to the development of metabolic and infectious diseases that has become a worldwide health issue[6]. Patients with CLD, such as non-alcoholic steatohepatitis(NASH), present impaired immune function, dysbiosis, insulin resistance (IR) and LGI, all of which can aggravate infectious disease progression and perpetuate excess of adipose tissue, are characterized by overstimulation of the production of adipose-derived inflammatory molecules[5,7-9].

    The liver also secretes important hepatokines that act as signaling proteins modulating functions in other organs and are involved in a wide range of conditions, such as IR and adipogenesis[1]. For instance, fibroblast growth factor-21 (FGF-21) is a mediator participating in glucose metabolism mainly secreted by the liver that modulates adipogenesis, while fetuins, liver-derived plasma proteins, are participating in metabolic impairment and inflammation[1]. A dysregulation in systemic cytokines prompts fat accumulation in hepatocytes, which in turn promotes local secretion of proinflammatory hepatokines, leading to liver steatosis and IR. In addition, immune cells also find difficulty in this inflammatory environment to exert their role appropriately. Persistent inflammatory signals over time also abnormally activate immune cells, impairing the body’s ability to fight infection, repair tissue damage, or recover from possible poisoning. Inflammation comes hand in hand with an increase in oxidative stress, a state characterized by an imbalance in favoring the accumulation of higher reactive oxygen (ROS) and nitrogen species. These molecules in unusual concentrations damage the cell and environmental milieu by promoting the expression of proinflammatory genes, resulting in a vicious cycle. Thus, CLD presents an oxidative atmosphere, probably linked to the proinflammatory state[10,11]. This environment is the perfect setting for the fibrogenic process to unfold, an underlying condition of CLD that is characterized by progressive accumulation of fibrillar extracellular matrix in the liver[12]. The stage of hepatic fibrosis has been associated with the risk of mortality and liver-related morbidity in patients with NAFLD[13], virus-induced hepatitis[14,15], and alcoholic-derived liver disease[16], eventually leading to HCC.

    In this context, infection by human hepatitis viruses (HHVs) is the most common cause of hepatitis,leading to the activation of the immune system, and the subsequent inflammatory response[17]. HBV and HCV acute infections can be resolved with antiviral and immune therapy. However, in a significant percentage they can progress to chronic hepatitis. This persistent infection can lead to comorbidities outside the liver, like arthritis, vasculitis, myalgia, and peripheral neuropathies[18]. Moreover, another new infectious disease appeared in late 2019 that can cause liver damage: Coronavirus disease 2019(COVID-19). COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)infection, and it has become a global health issue since its outbreak in 2020 was declared a pandemic.Beyond lung function, COVID-19 can affect a wide variety of tissues, like the gastrointestinal tract,kidneys, and liver, with an underlying adverse inflammatory environment[19]. This inflammatoryrelated condition has been strongly associated to metabolic status and worsening diseases like obesity,diabetes, and hypertension[7,20-22]. For instance, COVID-19 can increase hepatic lipid accumulation by mitochondrial and endoplasmic reticulum (ER) dysfunction or worsen NAFLD if it was already present.A recent systematic review depicted that the parameters normally used for liver impairment screening were significantly increased in COVID-19 patients[23], placing CLD as a risk factor for progressive and severe COVID-19[24,25].

    CLD is a global health problem, and new methods are needed to tackle this life-threatening condition.In this line, this review aims to explore machine learning (ML)-based approaches to manage CLD and develop biomarkers for diagnosis and prognosis. Its goal is to shed light on the factors involved in CLD to help health professionals in clinical management with the support of ML and identify new targets that can define therapeutic care lines in viral infections and non-communicable diseases (NCD), with an impact on liver functions with an inflammatory component. This includes the new disease, COVID-19.

    MECHANISMS BY WHICH NCD AND INFLAMMATORY/IR PHENOMENA CAN AFFECT LIVER FUNCTION

    The incidence of NCD, such as cardiovascular diseases and diabetes, has skyrocketed in the last decades, pressing authorities to establish developmental goals to achieve in the near future in terms of decreasing NCD-caused mortality[26]. Some of the risk factors that contribute to the development of NCD are excess of adipose tissue and high levels of glycemia. In this context, adipose tissue plays a key role in the development of FLD by secreting adipokines and other molecules, like free fatty acids (FFA)[8].

    An energy excess prompts fat accumulation in the organism and the subsequent dysregulation of this tissue. This is of relevance since an inflamed adipose tissue results in increased levels of FFA and proinflammatory cytokines, IR, and infiltration of macrophages in the liver by the activation of Th1 and Th17 cells[8]. FFA enter the liver through the portal vein and trigger a series of reactions. For instance,they serve as ligands to toll-like receptor-4 complex, stimulating the production of TNF-α through the activation of nuclear factor-kappa B, favoring an inflammatory environment. Moreover, the excess of fat drives the polarization state of this increased number of macrophages from anti-inflammatory M2 to proinflammatory M1 macrophages and prompts fat accumulation in the liver and IR[8]. Adiposederived macrophages also secrete inflammatory molecules, like TNF-α and IL-6, and adipokines, such as visfatin [also named nicotinamide phosphoribosyl transferase (NAMPT)]. NAMPT has gained relevance as a pivotal molecule linking adipose tissue and FLD. NAMPT is a pleiotropic molecule that can be found in an extracellular (eNAMPT) or an intracellular (iNAMP) form. Studies indicate that eNAMPT has enzyme and cytokine-like activity, stimulating the release of proinflammatory cytokines.Meanwhile, iNAMPT catalyzes the rate-limiting step in nicotinamide adenine dinucleotide (NAD+)formation. Because of this NAD+ boosting property, levels of iNAMPT have been proposed as beneficial for the homeostasis of the cell due to influencing the activity of NAD-dependent enzymes,such as sirtuins (SIRT). Remarkably, SIRT1 plays a key role in the liver by modulating the acetylation status of target molecules in lipid metabolism[27].

    Furthermore, IR is characterized by hyperglycemia and the subsequent hyperinsulinemia to counteract high glucose levels, being a risk factor for NCDs, particularly type 2 diabetes, where it has been closely linked to oxidative stress[28]. A normal insulin signaling pathway starts with the activation of the insulin receptor so that it can bind to phosphoinositide 3-kinase to ultimately activate protein kinase B (Akt). Activated Akt drives glucose entry into the cell by promoting GLUT4 expression and glycogen synthesis[29]. Oxidative stress impairs this signal transduction through many different mechanisms, like inhibiting the transcription factors insulin promoter factor 1 and peroxisome proliferator-activated receptor gamma, which mediate insulin and GLUT-4 expression, respectively.Moreover, under hyperglycemic conditions, fetuin A hepatokine inhibits the insulin receptor and promotes inflammation, while FGF-21 inhibits lipid accumulation and increases insulin sensitivity.Dysregulation of this hormones, together with oxidative stress imbalance, lead to impaired insulin signaling[30].

    The metabolic conditions underlying the development of NCD are complex, and they often reinforce each other, perpetuating an inflammatory environment and oxidative stress imbalance. As the orchestrating organ, these processes converge in the liver, affecting metabolic functions and setting the basis for the onset of the fibrogenic process characteristic of CLD.

    MECHANISMS BY WHICH VIRAL INFECTIONS AND INFLAMMATORY/IR PHENOMENA CAN AFFECT LIVER FUNCTION

    Persistent virus-associated liver damage can progress to CLD, which pressures health systems with a big social and economic burden. Although lots of resources have been invested to study the molecular mechanisms that mediate this process, results are diverse and still under investigation by the scientific community. HHVs directly infect hepatocytes, and the internalization into the cell is believed to happen by endocytosis, requiring the interaction with several host cell factors[17]. However, viral entry of HBV and HCV within hepatocytes is unclear, and further research is needed to elucidate this question.Sodium taurocholate co-transporting polypeptide was recently identified as an HBV receptor that would mediate HBV cell entry[31]. In the case of HCV, specific intercellular adhesion molecules appear key to cell adhesion and subsequent internalization[32].

    Regarding HBV and HCV replication, it has been found that liver X receptor-α (LXR-α) plays a key role. LXR-α is a transcription factor whose activation triggers the expression of different genes that directly or indirectly modulate these viruses’ replication as well as the lipid and inflammatory alterations associated to CLD[33]. This inflammation is also mediated by the nucleotide-binding oligomerization domain-like receptor protein 3, which is activated by the abnormal production of ROS after a viral infection occurs in the liver. This ROS increase is associated with a decreased expression of nuclear factor-e2-related factor-2, a transcription factor that regulates ROS/recepteur d’origine nantais balance by maintaining redox homeostasis. These alterations compromise the normal state of the cell,laying the foundations on which the fibrotic process of CLD begins[11].

    In the case of COVID-19, the mechanisms by which liver damage can occur are more unclear, but it is widely accepted that inflammation plays a huge role. This infection can trigger an exaggerated immune response leading to an uncontrolled cytokine release, also known as a “cytokine storm”. It is characterized by abnormal levels of IL-6, IL-1, C-C motif chemokine ligand (CCL)-5, chemokine (C-X-C motif)ligand (CXCL)-8, CXCL-1, and TNF-α among others[19]. This inflammatory cascade affects bile duct function since cytokines like TNF-α, IL-1, and IL-6, can induce hepatocellular cholestasis by downregulating hepatobiliary uptake and excretory systems[34].

    Furthermore, the presence of this inflammatory environment can upregulate the expression of angiotensin converting enzyme 2 (ACE2)receptor in different tissues, like the adipose tissue and the liver[35-39]. This is of relevance since ACE2 receptors are the main cell entrance of the SARS-CoV-2 virus, and they are present in different tissues. Particularly in the liver, the cholangiocytes (characteristic cells of the bile duct)[40], as well as liver vascular endothelial cells[41], express ACE2 receptors.Hepatocytes and cholangiocytes are permissive to the SARS-CoV-2 virus, mediating subsequent entrance into the liver[42]. Several studies have found thatACE2expression in hepatocytes is increased under hypoxia[43], a frequent condition in COVID-19 patients, and fibrotic conditions[44]. Besides ACE2 receptors, transmembrane serine protease 2 (TMPRSS2) and paired basic amino acid cleaving enzyme (FURIN) have been noted as significant for infection in the liver[45,46]. In this context,ACE2expression is increased in patients in HCV-related cirrhosis[44], whereasTMPRSS2andFURINexpression are upregulated in patients with obesity and NAFLD[47]. Moreover, infection by SARS-CoV-2 increases glucose-regulated protein 78 and 94, two biomarkers of ER stress[48,49], and impairs mitochondrial function[50]. This process is of interest since this state has been associated withde novolipogenesis in hepatocytes[51], which could eventually lead to steatosis in these patients.

    The use of therapeutic drugs can be another underlying cause of liver damage[3]. Because of detoxifying functions, the liver is subject to drug-induced damage coming from a wide range of approved drugs. Oncology drugs account for most hepatotoxicity cases, followed by those used for infectious diseases[3]. Since the beginning of the COVID-19 pandemic, a wide range of different treatments (antivirals, antibiotics, antimalaria, or corticosteroids) have been used in the absence of an efficient drug to treat severe infections. This pharmacological administration could explain that druginduced liver injury appears in nearly 25% of COVID-19 patients[23], a consequence to consider when addressing liver damage in this disease.

    ML APPROACHES IN INFLAMMATORY AND LIVER-RELATED COMORBIDITIES IN NONCOMMUNICABLE AND VIRAL DISEASES

    Despite all the advances in the mechanisms driving the onset of these diseases, new techniques to detect innovative biomarkers for diagnosis and prognosis as well as to discover novel drugs are needed, for example artificial intelligence (AI). AI seeks to mimic human behavior, and within this science, ML is the most common approach[52]. The advances in computational science in the last decades have permitted the development of powerful algorithms based on this science. ML algorithms are particularly relevant for biological research because they allow the processing and integration of the huge amount of data that the latest advances in this field have brought by applying statistical methods to enable machines to improve experiences. This methodological approach can be categorized into two big groups: Supervised and unsupervised learning. In supervised algorithms, data is tagged in order to train the algorithm and fit it appropriately, whereas if it is unsupervised, the algorithm learns patterns from unlabeled data[53]. ML algorithms are generally assessed by simple methodologies like sensitivity,specificity, and accuracy. While sensitivity evaluates the proportion of true positives correctly identified,specificity evaluates the proportion of true negatives. Meanwhile, the accuracy value indicates the number of times the model is correct[54].

    Supervised algorithms can be divided into two categories depending on the purpose: Prediction, in which the algorithm is fed and trained predictive models to data; or classification, which consists in clustering data within explanatory groups[55,56]. Predictive algorithms are based on regression models,and the most used are linear and logistic regression (LR), support vector machine (SVM), support vector regression (SVR), extra tree regression (ETR), artificial neural networks (ANN), and decision trees (DT).Regression models analyze the influence of one or multiple variables on a nominal or ordinal categorical outcome. ANN are more complex mathematical models (deep learning algorithms) that mimic the brain neural network, like the convolutional neural network (CNN), in which an input is fed through a hidden layer of many different well connected and structured nodes to produce a final output. In deep neuronal network (DNN) models, a great number of hidden successive layers use the output from the previous layer as input in a more complex algorithm. DT can also classify data, like random forest (RF)or gradient boosting (GB) models. Instead of minimizing error, these models determine thresholds derived from input data, assigning weight values to variables. Other models of classification are the Ada-Boost, Bayesian network (BN), Na?ve Bayes (NB), K-Nearest Neighbors (KNN), and linear discriminant analysis (LDA) that group data into clusters[55,56]. All these models can shed light into biological questions and are normally used indistinctively to obtain the best performance with the same dataset. For instance, Mijwil and Aggarwal[57] analyzed and compared 7 ML algorithms to predict appendix illness in the same dataset, revealing that certain models performed better than others,allowing for higher accuracy and results.

    In FLD, the common techniques used in diagnostics are based on techniques like ultrasonography and magnetic resonance imagining (MRI). These methods are subjective, and the informed outcome mainly relies on the interpretation of the professional carrying out the procedure. Several investigations have studied the implementation of ML in order to classify FLD and other liver diseases by using images from ultrasounds, computed tomography (CT), and MRI[58,59]. However, the downside of this approach is that the quality of the images differs from one another because of several factors, such as equipment precision and interpersonal differences, for instance. Therefore, there is a need for ML approaches to help in image segmentation, and some authors have already implemented this technique to improve clinical practice[60,61].

    Moreover, ML can help with the integration of more complex information beyond imaging to study and diagnose liver diseases since patients with CLD in the developmental phase require frequent follow-ups to check the progress of the disease and early detection changes in the diagnosis[58]. For example, patients with HHV-induced CLD are normally on antivirals. However, there is no consensus or guidelines about when to stop antiviral therapy or even if quitting these drugs will increase HCC risk. Therefore, new approaches need to be established to classify and prevent the development of more severe illnesses, like cirrhosis or cancer. In this line, ML approaches can be used to measure liver fibrosis, optimize diagnosis, and predict disease progression of CLD[62]. Table 1 summarizes selected studies that have used ML for these purposes, which have been collected for this review, and Table 2 summarizes the most repeated inputs from all compiled ML models along with the most repeated predictive results for the main four inflammation-related liver conditions.

    ML in inflammation-related liver disease

    In recent years, promising results have been found when applying ML approaches in CLD. Regarding prevention, Fialokeet al[63] screened 108139 patients to identify those diagnosed with benign steatosis and NASH, a type of NAFLD, train ML classifiers for NASH and healthy (non-NASH) populations, and predict NASH disease status on patients diagnosed with NAFLD according to aspartate transaminase(AST), alanine transaminase (ALT), and platelet (PLT) levels. In this line, another study detected body mass index (BMI), triglycerides (TG), gamma-glutamyl transpeptidase (GGT), ALT, and uric acid as the top 5 features contributing to NAFLD, with the BN model performing the best[64]. Accordingly, Yipet al[65] selected TG, ALT, white blood cell count, high-density lipoprotein cholesterol (HDL-c), glycated hemoglobin A1c (HbA1c), and the presence of hypertension as the six variables to build ML models, of which Ada-Boost outperformed the others individually and described the NAFLD status in 922 subjects.

    More recently, Peiet al[66] designed a ML model that integrated medical records as a clinical variable to classify FLD. Concretely, they selected the variables of age, height, BMI, hemoglobin, AST, glucose,uric acid, low-density lipoprotein cholesterol (LDL-c), alpha-fetoprotein, TG, HLD-c, and carcinoembryonic antigen. They tested six different ML models in 3419 participants, of which 845 were diagnosed with FLD: LR, RF, ANN, KNN, extreme gradient boosting (XGBoost) (a type of GB model), and LDA.Results from these authors showed that the XGBoost model had the highest performance, followed by LR and ANN, to predict the risk of FLD. BMI, uric acid, and TG levels were the top three variables associated to FLD risk across the six analyzed models.

    When it comes to diagnosis and treatment, several ML models have been tested for different purposes obtaining good specificity, sensitivity, and accuracy values[62]. For example, to determine the stage of liver fibrosis, some authors have used CT images processed by segmentation algorithms. Choiet al[67] used CNN upon CT images, whereas Chenet al[68] employed RF, KNN, SVM, and the NB classifiers with real-time tissue elastography imaging, age, and sex as feeding variables. In both cases,the ML approach outperformed the classical methods. Regarding treatment, different ML models have been used to define the best therapy for liver diseases such as carcinomas and virus-induced hepatitis.Jeonget al[69] used DNN to classify intrahepatic cholangiocarcinoma susceptible to adjuvant therapy following resection according to laboratory and clinicopathological markers and found it more accurate than the commonly used staging system.

    Wübboldinget al[70] studied the prediction of early virological relapse analyzing soluble immune markers using supervised ML approaches like KNN, RF, and LR. This study showed that IL-2,monokine induced by interferon γ/CCL9, RANTES/CCL5, stem cell factor, and TNF-related apoptosisinducing ligand in combination were more reliable in predicting virological relapse than viral antigens.In the same way, researchers have used ML classifiers to explore new methods able to better predict prognosis of liver diseases[71-74]. The weighted variables are usually CT images and/or biochemical parameters that involved invasive and costly methods. However, researchers have recently proposed volatile organic compounds as new biomarkers for progression and prognosis of liver disease. These researchers monitored isoprene, limonene, and dimethyl sulfide concentrations from a breath sample in liver patients compared to healthy subjects. They used regression ML models (LR, ETR, SVR, and RF) to demonstrate that these approaches together with breath profile data can predict clinical scores of liver disease[75]. These findings are promising and open the way for new, safe, and non-invasive approaches to study liver function and for diagnosis purposes.

    ML methods have been employed when studying the comorbidities of liver-related diseases, like obesity, diabetes, and cardiovascular diseases[53,55,76]. For example, ML algorithms have been built to study the risk factors associated to overweight and obesity development, showing that BMI, age, dietary pattern, blood test results, socioeconomic status, and sedentarism were key factors when studying excess of adipose tissue[77]. In this line, further research has revealed by ML techniques that the minutes devoted to physical activity in one week[78], as well as specific species of gut microbiota[79],are also crucial for obesity prediction. ML algorithms have also elucidated the risk factors of childhoodobesity, of which parental BMI and the upbringing environment play a huge role[80-82]. Furthermore,researchers have observed by training a multivariate LR model with a dataset of 3634 children and adolescents’ vitamin intake that vitamins A, D, B1, B2, and B12 were associated in a negative manner with obesity in this cohort[83]. These results are of interest since new insights are needed to discover novel targets to tackle comorbidities that affect liver function.

    Table 1 Summary of machine learning articles studying virus and inflammatory-related liver damage

    [75]function-related scores(MELD, APRI, CTP)using breath biomarkers compared to n = 17,liver patients metric data, blood biomarkers, breath analysis ETR 0.82, and 0.85 for CTP score, APRI score, and MELD,respectively, by ETR dimethyl sulfide can be potential biomarkers for liver disease Butt et al[85]To diagnose the stage of hepatitis C n = 968, patients with HCV Age, anthropometric data, blood biomarkers, and histological staging ANN, RF,SVM,XGBoosting 98.89% precision by ANN The model performed better than previously presented models by other authors Wei et al[87]To predict HBV and HCV-related hepatic fibrosis n = 490, HBV patients; n= 254, and 230 HCV patients Age, BMI,analytical data(FIB-4 score), and liver biopsy GB, DT, RF AUROC of 0.918 by GB GB outperformed the FIB-4 predictive score Barakat et al[89]To predict and stage hepatic fibrosis in children with HCV n = 166, children with CHC Analytical data(APRI and FIB-4 scores)RF AUCs of 0.903 for any type of fibrosis RF outperformed FIB-4 and APRI predictive score Konerman et al[88]To predict progression of HCV n = 72683, veterans with CHC Age, BMI,demographic, and blood biomarkers(APRI score)CS and LGT Cox and boosting AUROC of 0.830 and 0.77 sensitivity by LGT boosting model for 1 yr follow-up APRI and PLT count were top predictors in the LGT boosting model Wong et al[86]To predict HCC in patients with CVH n = 86804, CHV patients, of which 6821 with HCC Age, sex, clinical data, and blood biomarkers LR, RIDGE regression,AdaBoosting,RF, DT AUROC of 0.992 and 0.837 by RF in training and validation cohort,respectively ML models obtained better AUROCs than HCC traditional risk scores Feldman et al[91]To predict DAA therapy duration in hepatitis C n = 3943, HCV patients with sofosbuvir/ledipasvir as the first course of DAA,of which n = 240,received the prolonged DAA treatment Age, sex, and clinical data(including hepatitis C record data)XGBoosting,RF, SVM AUC of 0.745 by XGBoosting Results showed age,comorbidity burden, and type 2 diabetes status as new predictors for DAA therapy duration Kamboj et al[92]To predict repurposed drugs for HCV n = 17968 HCV molecular fingerprints Experimentally validated small molecules from the ChEMBL database with bioactivity against HCV NS3,NS3/A4, NS5A and NS5B proteins SVM, ANN,KNN, RF R2 value of 0.92 by SVM Results identified more than 8 repurposed treatments anti-HCV Tian et al[93]To predict HBsAg seroclearance n = 2235, patients with CHB, of which 106 achieved HBsAg seroclearance Age, BMI,demographic and clinical data, and blood biomarkers LR, RF, DT,XGBoosting AUC of 0.891 by XGBoosting Level of HBsAg followed by age and HBV DNA were the top predictors Chen et al[94]To predict HBVinduced HCC using quasispecies patterns of HBV n = 307, CHB patients; n= 237, HBV-related HCC patients rt nucleic acid and rt/s amino acid sequences SVM, RF,KNN, LR AUC of 0.96, and accuracy of 0.90 by RF HBV rt gene features can efficiently discriminate HCC from CHB Mueller-Breckenridge et al[95]To classify HBeAg status in HBV patients using virus full-length genome quasispecies n = 352, CHB untreated patients Matrix of allele frequencies (0.1-0.99) and the associated HBeAg status RF Range balanced accuracy of 0.8-1 n1896GA, n1934AT,n1753TC mutants were the highest-ranking variables Kayvanjoo et al[96]To predict HCV interferon/ribavirin therapy outcome based on viral nucleotide attributes n = 76, gene attributes HCV nucleotide attributes DT, SVM, NB,DNN Accuracy of 84.17% by SVM in responder vs relapser of subtype 1b sequences Dinucleotides UA and UU were top predictors in the combination treatment outcome Li et al[98]To distinguish influenza from COVID-19 patients n = 398, COVID-19 and influenza cases Age, sex, blood biomarkers,clinical data, and CT and X-ray scans XGBoosting,RF, and LASSO and RIDGE regression models AUC of 0.990,sensitivity of 92.5% and a specificity of 97.9% by XGBoosting Age, CT scan result, and temperature were top three predictors Bhargava et al To detect novel n = 31454, images CT or X-ray scans KNN, SRC,99.14 of accuracy SVM model classified with

    [99]COVID-19 and discriminate between pneumonia acquired from nine distinct datasets of COVID-19 patients ANN, SVM by SVM the highest recognition rate the images as normal,pneumonia, and COVID-19 positive Bennett et al[97]To predict early severity and clinically characterize COVID-19 patients n = 174568, patients with a positive lab test for COVID-19 Age, sex,demographic,anthropometric and clinical data,and blood biomarkers RF, LR,XGBoosting AUROC of 0.87 by XGBoosting Age, oxygen respiratory rate, and blood urea nitrogen were ranked as top predictor for severity outcome Günster et al[100]To identify independent risk factors for 180-d allcause mortality in COVID-19 patients n = 8679, hospitalized COVID-19 patients Age, sex, BMI, and clinical data LR AUC of 0.81 A high BMI and age were strong risk factors for 180-d all-cause mortality, while female sex was protective Deng et al[101]To identify clinical indicators for COVID-19 n = 379, patients, 62 with COVID-19 and 317 with pneumonia Age, sex,demographic and clinical data, and blood biomarkers EBM AUC of 0.948 Variables grouped under liver function was top the predictor category for COVID-19 prediction Lipták et al[102]To identify gastrointestinal predictors for the risk of COVID-19-related hospitalization n = 680, patients Age, sex, clinical data, and blood biomarkers RF AUC of 0.799 AST was top predictor for hospitalization Elemam et al[103]To identify immunological and clinical predictors of COVID-19 severity and sequelae n = 37, COVID-19 patients; n = 40, controls Age, sex, BMI,clinical data, and blood biomarkers Stepwise linear regression AUC of 0.93 for cytokines as predictors. AUC of 0.98 for biochemical markers as predictors IL-6 and granzyme B were top potential predictors of liver injury in COVID-19 patients Mashraqi et al[104]To predict adverse effects on liver functions of COVID-19 ICU patients n = 140, COVID-19 patients admitted to ICU Blood biomarkers and existence of liver damage SVM, KNN,ANN, NB, DT AUC of 0.857 and precision of 0.95 by SVM AST and ALT were top predictors of liver damage in these patients Soltan et al[106]To evaluate a laboratory-free COVID-19 triage for emergency care n = 114957, emergency presentations prior to the global COVID-19 pandemic and n = 437,COVID-19 positive Blood biomarkers,blood gas, and vital signs LR,XGBoosting,RF AUROC range of 0.9-0.94 by XGBoosting for datasets The model could effectively triage patients presenting to hospital for COVID-19 without lab results Gao et al[111]To predict mortality in patients with alcoholic hepatitis n = 210, alcoholic hepatitis patients Age, clinical data,blood biomarkers,and omics data sets (metagenomics,lipidomics, and metabolomics)GB, LR, SVM,RF AUC of 0.87 by GB for 30-d mortality prediction using the dataset combining clinical data,bacteria and MetaCyc pathways and for and 90-d mortality prediction using the fungi dataset The model performed better than the currently used MELD score NASH: Non-alcoholic steatohepatitis; NAFLD: Non-alcoholic fatty liver disease; CHB: Chronic hepatitis B virus infection; HCC: Hepatocellular carcinoma;HCV: Hepatitis C virus; CHC: Chronic hepatitis C virus infection; CVH: Chronic viral hepatitis; RF: Random forest; DT: Decision trees; LR: Logistic regression; SVM: Support vector machine; KNN: K-nearest neighbors; BN: Bayesian network; NB: Na?ve Bayes; AODE: Aggregating one-dependence estimators; FLD: Fatty liver disease; ANN: Artificial neural networks; LDA: Linear discriminant analysis; CNN: Convolutional neural network; DNN: Deep neuronal network; SRC: Sparse representative classifier; EBM: Explainable boosting machine; CS: Cross-sectional; LGT: Longitudinal; HBsAg: Hepatitis B surface antigen; HBeAg: Hepatitis B virus e antigen; BMI: Body mass index; ALT: Alanine transaminase; AST: Aspartate transaminase; APRI: Aspartate transaminase/platelet ratio index; COVID-19: Coronavirus disease 2019; CT: Computed tomography; GB: Gradient Boosting; AUC: Area under the curve;AUROC: Area under the receiver operating characteristic curve; ICU: Intensive care unit; IL-6: Interleukin 6; DAA: Direct-acting antiviral; MELD: Model for end-stage liver disease; TG: Triglycerides; HbA1c: Glycated hemoglobin A1c; ICC: Intrahepatic cholangiocarcinoma; ML: Machine learning; ETR: Extra tree regression; AJCC: American Joint Committee on Cancer; CXCL: chemokine (C-X-C motif) ligand; CCL: C-C motif chemokine ligand; SVR: Support vector regression; MIG: Monokine induced by interferon γ; SCF: Stem cell factor; TRAIL: Tumor necrosis factor-related apoptosis-inducing ligand; PLT:Platelet; GGT: Gamma-glutamyl transpeptidase; HDL-c: High density lipoprotein cholesterol; FIB-4: Fibrosis-4; HBV: Hepatitis B virus; TACE:Transarterial chemoembolization; BCLC: Barcelona Clinic Liver Cancer.

    Table 2 Summary of the most repeated inputs of the machine learning models with the most repeated predictor outcomes for the four main inflammatory-related liver conditions

    ML in hepatitis virus-induced liver damage

    HBV and HCV infections can dangerously become chronic if not treated early and with the right treatment[84]. While scientists are still relentlessly working on an effective vaccine against HCV, a good and efficient diagnosis is key to prevent chronic HCV infection (CHC), and ML algorithms have been elucidated for this purpose. Thus, Buttet al[85] designed an ANN model and trained it with a dataset of 19 variables, among which age, sex, BMI, transaminase, and PLT count levels were included. The algorithm was able to better identify the stage of hepatitis C compared to other XGBoost, RF, and SVM models tested by other researchers with a higher precision rate and a decreased miss rate.

    ML algorithms have been applied and compared to traditional methods used to follow HHV-induced advanced liver disease[86-88]. For instance, Weiet al[87] used a GB model trained with the same variables that the formula fibrosis-4 (FIB-4) uses, which are age, AST, ALT and PLT levels in a cohort of 490 HBV patients, and two cohorts of HCV patients (n= 240 each). The GB model outperformed FIB-4 score in classifying hepatic fibrosis and the existence of cirrhosis. Barakatet al[89] designed an RF model that also outperformed the FIB-4 score, as well as the AST/PLT ratio index (APRI), for prediction and staging of fibrosis in children with hepatitis C. In this line, data of 72683 veterans with CHC were used to predict the progression of the disease. GB models were used and compared with cross-sectional or linear models fed with variables like transaminases levels, alkaline phosphatase (ALP), PLT, AST, APRI,albumin, bilirubin, glucose, white blood cells, and BMI were included in the dataset. Results showed that APRI, PLT, AST, albumin, and AST/ALT ratio were the best predictors for featuring CHC progression[88].

    Regarding therapy, CHC can be effectively treated with direct-acting antiviral (DAA) therapy, a novel treatment that targets viral non-structural proteins. Although it has null side effects compared to standard treatment, it has some downsides. Treatment failure in a low percentage of the cases, a very high cost, and no treatment duration established[90]. New methods to define this therapy duration are needed to optimize adherence and success. Feldmanet al[91] studied the prediction of DAA treatment duration in hepatitis C patients using XGBoost, RF, and SVM models. They used the dataset of 240 patients with prolonged first course of DAA against another dataset of 3478 patients on standard duration. Age, sex, comorbidities, and previous hepatitis C treatment record were considered. The predictive model constructed with XGBoost obtained the best performance in predicting prolonged DAA treatment, in which the presence of cirrhosis, type 2 diabetes, age, HCC, and previous standard treatment were the most determining variables. Meanwhile, Kambojet al[92] used ML approaches in the search of repurposed drugs that could target non-structural proteins, developing regression-based algorithms able to identify inhibitors of these proteins, and proposing new drugs to test in CHC.

    A huge milestone when treating chronic HBV infection (CHB) is seroclearance of HBV surface antigen (HBsAg)[84]. It has been demonstrated that seroclearance of HBsAg is associated to a better prognosis in CHB. Some authors used ML models to predict HBsAg seroclearance in a cohort of 2235 patients, of which 106 achieved it. They used XGBoost, RF, and LR, among other models, and tested a total of 30 categorical and continuous variables, including sex, drinking history, initial diagnosis and treatment, age, BMI, and serum and radiological indicators. Results revealed that the XGBoost model showed the best predictive performance, indicating that HBsAg levels were the best predictor for HbsAg seroclearance, followed by age, and the DNA level of HBV[93].

    Interestingly, ML has also contributed to personalized medicine in this field. HHVs evolve and adapt to different cellular environments in order to escape immune responses and drugs to survive. These adaptations rely on high mutagenetic activity, especially within the target genes of antivirals. Regarding HBV, Chenet al[94] used ML to identify patients with HCC or CHB based solely on genetic differences and found that the RF model impressively discriminated both cases based on thertgene sequence of HBV. Moreover, Mueller-Breckenridgeet al[95] ultra-deep sequenced 400 HBV samples and used an RF model to classify the status of a particular HBsAg according to the novel viral variants encountered.Results showed five genotypes that could benefit from personalized healthcare. In the case of HCV,Kayvanjooet al[96] built several ML algorithms and trained them with two datasets of respondersvsnon-responders of antiviral therapy in HCV infection caused by two different strains. These investigations reported novel genetic markers that could predict therapy response with high accuracy. These results are very promising since they contribute to bringing personalized medicine to the public system.

    ML in COVID-19-induced liver damage

    A recent systematic review depicted that the parameters normally used for liver impairment screening were significantly increased in COVID-19 patients[23]. Particularly, several studies showed that levels of AST and/or ALT can increase in these patients up to 20%, bilirubin up to 14%, ALP up to 6%, and GGT levels up to 21%. Prothrombin is a protein synthesized in the liver that results in thrombin, a protein with a critical role in coagulation function. Prolonged prothrombin is a symptom of decreased production of coagulation factors, characteristic of liver disease. For this reason, the prolonged prothrombin time (PT) is another parameter usually checked when screening for liver injury, and it has been described that COVID-19 patients present nearly a 10% increase in PT[23]. Besides biochemical alterations, COVID-19 illness can lead to hypoxemia, impaired cardiac function, and secondary damage due to multiple organ dysfunction, which can result in liver injury in patients with or without prior liver disease. Therefore, new insights of the relationship between this recent infectious illness and liver disease are expected.

    The use of ML approaches has been encouraged by the National COVID Cohort Collaborative Consortium for early detection, prediction, and follow-up of severe COVID-19 cases since the pandemic started[97]. For instance, some researchers used the XGBoost approach and found that age, CT scan result, body temperature, lymphocyte levels, fever, and coughing can classify influenza patients from COVID-19 patients[98]. Bhargavaet al[99] tried different ML approaches to detect novel COVID-19 and discriminate between pneumonia using CT andX-ray scans as inputs. These authors pre-processed the images by normalization and then segmented them by fuzzy c-means clustering. Results showed that the SVM model was the one that better classified patients in COVID-19 positive, pneumonia, and healthy groups, obtaining a very high accuracy.

    In this same line, obesity and liver disease were identified as risk factors for higher clinical severity in a cohort of 174568 adults with severe acute respiratory syndrome associated with SARS-CoV-2 infection by a multivariable LR model[97]. Interestingly, a German study of 8679 patients used an LR model and identified liver disease and BMI as determinant risk factors for 180-d all-cause mortality in hospitalized COVID-19 patients[100]. A case-control study with COVID-19 patients compared to patients with community-acquired pneumonia showed how, by applying a GB model, the category of liver function appeared as one of the top systematic predictors for COVID-19 risk factors, with albumin, total bilirubin, and ALT among the most important input variables[101]. Furthermore, a study with 710 enrolled patients diagnosed with COVID-19 identified AST levels as the top predictor for COVID-19-related hospitalization based on an RF algorithm, followed by age and diabetes mellitus[102].

    A stepwise linear regression model identified IL-6 and granzyme B as potential predictors of liver dysfunction, characterized by an elevation in the levels of ALT and/or AST[103]. Other authors designed a model for detecting liver damage testing different ML approaches with laboratory parameters as the input variables. SVM was the model with the best accuracy, and AST and ALT levels were the variables with the best predictive scores[104]. In this context, the newest version of the CURIAL model was developed to identify COVID-19 patients using vital signs, blood gas, and laboratory blood tests. It showed greater sensitivity, making this model a potential emergency workflow[105,106]. All these ML-based methods would dramatically improve the time to diagnosis, free hospital laboratories and rooms of potential positive subjects, and reduce costs if implemented in the public health system.

    AI has also been employed to discover potential efficient new drugs to tackle SARS-CoV-2 infection[107]. Baricitinib is a drug initially approved for rheumatoid arthritis that was selected by ML as a potential drug to treat COVID-19. Researchers proved the anti-inflammatory and antiviral properties of this drug in human liver spheroids infected with live SARS-CoV-2 to check any potential drug-induced liver injury[107]. Due to the good results, researchers moved on to a clinical trial where they tested baricitinib in a few COVID-19 patients. Levels of liver enzymes were not altered, except for a transient increase in liver aminotransferases in all patients that remitted in the following 72 h without interrupting treatment. The authors stated that this might be reflective of disease severity rather than a drug-induced injury, showing overall good tolerance and results in this pilot study[108]. In summary,ML approaches support liver biochemistry as a prognostic tool in COVID-19 disease.

    PERSONALIZED MEDICINE IN LIVER-RELATED DISEASES SUPPORTED BY ML

    In the early 21stcentury, the Human Genome Project started the genomic era in which new disciplines like precision medicine appeared. Precision medicine aims to deliver targeted treatments based on a group of individual factors that greatly influence the onset and progression of a disease, like omics sciences. This approach covers a great number of patients, overcoming potential adverse effects and ensuring effectiveness of the treatment. In this context, computational advances have greatly contributed to the escalation of this science by lowering the costs of omics analysis and allowing the processing and integration of an enormous amount of data based on ML algorithms (Figure 2).

    ML has permitted the development of diagnostics and therapeutics based on the integration of omics data (genomics, epigenomic, transcriptomics, proteomics, metabolomics, and metagenomics) with clinical data. The ultimate goal is to bridge these omics data with the phenotype to bring molecular accuracy to the diagnosis, treatment, prognosis, and recurrence process of a pathological condition. This methodology has been used in a wide range of diseases in the search for more efficient and effective approaches, like heart and liver diseases[109,110]. For example, ML algorithms fed with omics data have been able to predict mortality in patients with alcoholic hepatitis. In this study, routine clinical variables of 210 patients with this disease were used to build six different datasets to assess mortality at 30 d and 90 d. Five different ML models were tested, obtaining the best performance in predicting 30-d mortality with a GB model using bacteria, MetaCyc pathways, and clinical data, as well as LR using viral and clinical data[111].

    In hepatitis B, it has been found that ML algorithms can be very useful in assessing HBV-associated HCC progression. Yeet al[112] analyzed 67 HBV-positive HCC samples with or without intrahepatic metastases and discovered key genes for metastatic progression and survival training ML models. The majority of them were inflammatory or related to the inflammation process, like IL-2 receptor and osteopontin, which encodes an extracellular cytokine ligand whose overexpression favors metastasis.These authors were able for the first time to draw a molecular signature useful to classify metastatic HBV-HCC patients, opening the way for early detection and new treatments to increase patient survival. In hepatitis C, the CC and CT genotypes of the rs12979860 polymorphism in theIL28Bgene have been associated with liver fibrosis progression, being able to predict antiviral treatment effectiveness[113].

    Moreover, ML algorithms have allowed the diagnosis of advanced liver fibrosis according to the rs12979860 genotype with higher performance compared to APRI and FIB-4 scores[114]. In this study,patients were divided into two groups according to HCV-related liver fibrosis stage: None to moderate fibrosis (n= 204); or with advanced fibrosis (n= 223). ML algorithms revealed theIL28Bgenotype as the first predictor, while the second predictor depended on the mentioned genotype. For instance, in CT patients, PLT, albumin, and age were the determining variables, while for patients with the TT genotype, white blood cell count was the decisive feature to assess advanced fibrosis probability.

    ML approaches have also helped to categorize obesity in different subtypes based on metabolic status[115-117]. For example, Masiet al[115] studied a cohort of 2567 subjects suffering from obesity and made clusters of metabolically healthy or metabolically unhealthy patients based on clinical and biochemical variables using two ML models. The first model showed that IR, body fat, HbA1c, red blood cells, age,ALT, uric acid, white blood cells, insulin growth factor-1, and GGT were the top predictors of a metabolically healthy obesity, revealing the importance of liver function.

    Other authors have also used ML models to classify 882 obese patients in subtypes of obesity according to glucose, insulin, and uric acid levels[116]. Results showed four stable metabolic clusters in this cohort, which were characterized by a healthy metabolic status, or by hyperuricemia, hyperinsulinemia, and hyperglycemia, respectively. Furthermore, Leeet al[117] explored three-way interactions between genome, epigenome, and dietary/lifestyle factors using GB and RF models in a subset (n= 394)of the exam 8 of the Framingham Offspring Study cohort. Interestingly, GB obtained the best performance, revealing 21 single nucleotide polymorphisms, 230 methylation sites in relevant genes(likeCPT1A,ABCG1, andSREBF1), and 26 dietary factors as top predictors for obesity. Intake of processed meat, artificially sweetened beverages, French fries, and alcohol intake, among other dietary factors, were highly associated with overweight/obesity.

    Personalized and precision medicine aims to harmonize the greatest number of factors so that diagnosis, prognosis, and treatment are based on the greatest number of decision elements. Much remains to be investigated to establish guidelines in the context of personalized medicine. However, it is safe to say that precision medicine will drive modern medicine, combining the most classic variables with the newest digital variables. Health professionals must be prepared to understand and implement these new technologies in the near future.

    CONCLUSION

    In summary, ML science can process and integrate a vast amount of different data with unprecedented outstanding performance. The objective of this article was to collect the information derived from ML techniques in liver damage induced by inflammatory conditions, including the new disease COVID-19.The main role of ML in liver pathologies is to help identify high risk patients for referral to specialized centers. Results show that the use of ML models have brought new insights into biology and medicine questions that can be very useful in determining the next directions for research in diagnosis, prognosis,and treatment of inflammatory and virus-related liver diseases, leading the way to personalized medicine. Also inflammation/IR biomarkers related to liver disease can be boosted by ML strategies.This review clarified and compiled the importance of the different factors involved in CLD and analyzed by ML algorithms, which can be useful information for clinicians, like endocrinologists and gastroenterologists, and other healthcare professionals with a focus on hepatology and bioinformatics.

    FOOTNOTES

    Author contributions:Martínez JA and Alonso-Bernáldez M contributed equally to this work as first co-authors. Martí nez JA and Ramos-Lopez O conceived and designed the study; Martínez JA, Alonso-Bernáldez M, and Ramos-Lopez O performed the search of articles and wrote the draft of the manuscript; Martínez-Urbistondo D, Vargas-Nu?ez JA,Dávalos A, and Ramos-Lopez O contributed to the analysis and critical interpretation of the data; and all authors read and approved the final manuscript.

    Supported bythe Community of Madrid and the European Union, through the European Regional Development Fund (ERDF)-REACT-EU resources of the Madrid Operational Program 2014-2020, in the action line of R + D + i projects in response to COVID-19, FACINGLCOVID-CM”; Synergic R&D Projects in New and Emerging Scientific Areas on the Frontier of Science and Interdisciplinary Nature of The Community of Madrid, METAINFLAMATIONY2020/BIO-6600.

    Conflict-of-interest statement:All the authors report no relevant conflicts of interest for this article.

    Open-Access:This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BYNC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

    Country/Territory of origin:Mexico

    ORCID number:J Alfredo Martínez 0000-0001-5218-6941; Ana Ramírez de Molina 0000-0003-1439-7494; Omar Ramos-Lopez 0000-0002-2505-1555.

    S-Editor:Wang JJ

    L-Editor:Filipodia

    P-Editor:Wang JJ

    99在线视频只有这里精品首页| 夜夜看夜夜爽夜夜摸| 啦啦啦免费观看视频1| 久久久国产精品麻豆| 国产精华一区二区三区| 精品久久久久久成人av| 国内精品一区二区在线观看| 丁香欧美五月| 制服丝袜大香蕉在线| 中文字幕精品亚洲无线码一区| 亚洲天堂国产精品一区在线| 精品少妇一区二区三区视频日本电影| 亚洲美女视频黄频| a级毛片在线看网站| 午夜福利成人在线免费观看| 日本熟妇午夜| av国产免费在线观看| 久久人妻福利社区极品人妻图片| av片东京热男人的天堂| 国产熟女xx| 欧美+亚洲+日韩+国产| 哪里可以看免费的av片| 毛片女人毛片| 亚洲在线自拍视频| 色哟哟哟哟哟哟| 久久婷婷人人爽人人干人人爱| 51午夜福利影视在线观看| 亚洲人与动物交配视频| 一级毛片女人18水好多| 一区二区三区高清视频在线| 黄色视频不卡| 18禁黄网站禁片午夜丰满| 99精品在免费线老司机午夜| 日本免费一区二区三区高清不卡| 亚洲精品粉嫩美女一区| 99久久国产精品久久久| 黑人操中国人逼视频| 亚洲av成人不卡在线观看播放网| 亚洲人成77777在线视频| 麻豆成人午夜福利视频| 亚洲av成人精品一区久久| 国产精品一区二区精品视频观看| 18禁黄网站禁片免费观看直播| 我要搜黄色片| 亚洲欧美精品综合久久99| 熟女少妇亚洲综合色aaa.| 日韩国内少妇激情av| 亚洲美女黄片视频| 黄频高清免费视频| 老司机福利观看| 欧美 亚洲 国产 日韩一| 免费看a级黄色片| av在线天堂中文字幕| 欧美色欧美亚洲另类二区| 99久久99久久久精品蜜桃| 成人av一区二区三区在线看| 亚洲av成人av| 日韩有码中文字幕| 人人妻人人看人人澡| 亚洲av成人不卡在线观看播放网| 淫秽高清视频在线观看| 久久久精品国产亚洲av高清涩受| 亚洲国产日韩欧美精品在线观看 | 国产成人av激情在线播放| 亚洲人成网站在线播放欧美日韩| 丰满人妻一区二区三区视频av | 一a级毛片在线观看| 亚洲七黄色美女视频| 老司机午夜福利在线观看视频| 超碰成人久久| 国产高清激情床上av| av超薄肉色丝袜交足视频| 亚洲第一电影网av| 亚洲 欧美 日韩 在线 免费| 亚洲精品粉嫩美女一区| 亚洲成a人片在线一区二区| 中文资源天堂在线| 亚洲美女黄片视频| 夜夜爽天天搞| 最近最新中文字幕大全电影3| 国产亚洲精品久久久久久毛片| 丰满的人妻完整版| 久久性视频一级片| 麻豆一二三区av精品| 99在线视频只有这里精品首页| 亚洲av电影在线进入| av片东京热男人的天堂| 岛国在线观看网站| 婷婷六月久久综合丁香| 嫁个100分男人电影在线观看| 欧美久久黑人一区二区| 精品国产超薄肉色丝袜足j| 波多野结衣高清作品| 少妇裸体淫交视频免费看高清 | 成人永久免费在线观看视频| 精品国产亚洲在线| 哪里可以看免费的av片| 亚洲欧美激情综合另类| 天天一区二区日本电影三级| 亚洲精品久久成人aⅴ小说| 中国美女看黄片| 91老司机精品| 婷婷精品国产亚洲av在线| 久久久精品欧美日韩精品| 首页视频小说图片口味搜索| av免费在线观看网站| 免费电影在线观看免费观看| 日本一区二区免费在线视频| 欧美绝顶高潮抽搐喷水| 黄色女人牲交| 久久九九热精品免费| 久久人妻av系列| 我的老师免费观看完整版| 国产精品香港三级国产av潘金莲| 又大又爽又粗| 啦啦啦韩国在线观看视频| 嫩草影视91久久| 精品国产乱码久久久久久男人| 老司机福利观看| 精品不卡国产一区二区三区| АⅤ资源中文在线天堂| 亚洲成人久久爱视频| 免费一级毛片在线播放高清视频| 久久久久久九九精品二区国产 | 变态另类成人亚洲欧美熟女| 久久久水蜜桃国产精品网| 午夜激情福利司机影院| 成人高潮视频无遮挡免费网站| 久久精品夜夜夜夜夜久久蜜豆 | 精品福利观看| 十八禁网站免费在线| 黄色片一级片一级黄色片| 韩国av一区二区三区四区| 少妇人妻一区二区三区视频| 午夜福利在线观看吧| 国产成人av激情在线播放| 97碰自拍视频| 亚洲av第一区精品v没综合| 亚洲国产中文字幕在线视频| 老司机靠b影院| 成在线人永久免费视频| 中出人妻视频一区二区| 国产午夜福利久久久久久| 国产精品日韩av在线免费观看| 欧美黄色淫秽网站| 久久香蕉精品热| 国产黄a三级三级三级人| 亚洲人成伊人成综合网2020| 变态另类成人亚洲欧美熟女| 国产三级黄色录像| 欧美极品一区二区三区四区| 不卡一级毛片| 欧美性猛交╳xxx乱大交人| 欧美另类亚洲清纯唯美| 精品国产亚洲在线| 国产伦人伦偷精品视频| 国产成人av激情在线播放| av天堂在线播放| 人成视频在线观看免费观看| 一级毛片女人18水好多| 99re在线观看精品视频| 国产亚洲av嫩草精品影院| 99久久99久久久精品蜜桃| 一a级毛片在线观看| 欧美乱妇无乱码| 9191精品国产免费久久| 精品国产美女av久久久久小说| 成人av在线播放网站| 无限看片的www在线观看| 精品人妻1区二区| 色综合站精品国产| 麻豆成人午夜福利视频| 亚洲国产精品久久男人天堂| 欧美高清成人免费视频www| 亚洲av成人不卡在线观看播放网| 精品国产美女av久久久久小说| 亚洲国产欧美一区二区综合| 久久久国产成人精品二区| 欧美性猛交黑人性爽| 国产日本99.免费观看| 亚洲午夜精品一区,二区,三区| 丰满人妻一区二区三区视频av | 国产精品免费一区二区三区在线| 日本撒尿小便嘘嘘汇集6| 岛国在线观看网站| 天堂√8在线中文| 亚洲成a人片在线一区二区| av免费在线观看网站| 麻豆国产97在线/欧美 | 天天躁狠狠躁夜夜躁狠狠躁| 午夜福利视频1000在线观看| 亚洲自偷自拍图片 自拍| 国产精品,欧美在线| 午夜老司机福利片| 国产精品亚洲一级av第二区| 久久中文字幕人妻熟女| 50天的宝宝边吃奶边哭怎么回事| 日韩成人在线观看一区二区三区| 亚洲欧美日韩高清专用| 曰老女人黄片| 露出奶头的视频| 国产久久久一区二区三区| 亚洲中文字幕一区二区三区有码在线看 | 国产亚洲欧美在线一区二区| 国产v大片淫在线免费观看| 精品一区二区三区视频在线观看免费| 51午夜福利影视在线观看| 亚洲欧美日韩高清在线视频| 久久精品夜夜夜夜夜久久蜜豆 | 精品少妇一区二区三区视频日本电影| 国产精品爽爽va在线观看网站| √禁漫天堂资源中文www| 777久久人妻少妇嫩草av网站| 美女免费视频网站| 亚洲成人久久爱视频| 欧美一级a爱片免费观看看 | 亚洲欧美精品综合久久99| 悠悠久久av| 亚洲av熟女| 亚洲精品av麻豆狂野| 日韩精品免费视频一区二区三区| 国产精品美女特级片免费视频播放器 | 在线观看66精品国产| 久久久久久国产a免费观看| 亚洲国产中文字幕在线视频| 午夜福利18| 国产亚洲av嫩草精品影院| 超碰成人久久| 琪琪午夜伦伦电影理论片6080| 蜜桃久久精品国产亚洲av| 日韩欧美 国产精品| 国产精品久久久久久人妻精品电影| 国产99久久九九免费精品| av国产免费在线观看| 操出白浆在线播放| 欧美三级亚洲精品| 久久久久久久精品吃奶| 成人欧美大片| 亚洲男人天堂网一区| 国产v大片淫在线免费观看| 12—13女人毛片做爰片一| 母亲3免费完整高清在线观看| 国产av麻豆久久久久久久| 草草在线视频免费看| 午夜激情福利司机影院| 两个人的视频大全免费| 久久精品91无色码中文字幕| 在线十欧美十亚洲十日本专区| 老汉色av国产亚洲站长工具| 亚洲avbb在线观看| 村上凉子中文字幕在线| 亚洲人与动物交配视频| 色哟哟哟哟哟哟| 一个人观看的视频www高清免费观看 | www日本黄色视频网| 夜夜看夜夜爽夜夜摸| 日韩精品免费视频一区二区三区| 久久精品国产亚洲av高清一级| 久久草成人影院| 两个人的视频大全免费| 桃红色精品国产亚洲av| 欧美精品亚洲一区二区| 亚洲av日韩精品久久久久久密| 国产高清videossex| 日韩欧美精品v在线| 久久久国产成人免费| 亚洲午夜精品一区,二区,三区| 淫秽高清视频在线观看| 日日爽夜夜爽网站| 波多野结衣高清作品| 国产久久久一区二区三区| 午夜福利18| 操出白浆在线播放| 亚洲成人久久性| 欧美成人一区二区免费高清观看 | 女同久久另类99精品国产91| 日韩av在线大香蕉| 搞女人的毛片| 久久中文字幕一级| 久久精品国产综合久久久| 亚洲18禁久久av| 国产精品永久免费网站| 啦啦啦免费观看视频1| 99热6这里只有精品| 999精品在线视频| 日本 欧美在线| 国产免费男女视频| 叶爱在线成人免费视频播放| netflix在线观看网站| 十八禁网站免费在线| 伦理电影免费视频| 国产精品av视频在线免费观看| 国产精品亚洲av一区麻豆| 老熟妇仑乱视频hdxx| 俺也久久电影网| 国产伦一二天堂av在线观看| 久久精品综合一区二区三区| 欧美最黄视频在线播放免费| 波多野结衣高清作品| 日韩欧美国产在线观看| 丰满的人妻完整版| 国产片内射在线| 日韩 欧美 亚洲 中文字幕| 成年免费大片在线观看| 成人国产一区最新在线观看| 在线观看日韩欧美| 12—13女人毛片做爰片一| 日韩大码丰满熟妇| av福利片在线观看| 色精品久久人妻99蜜桃| 国产精品1区2区在线观看.| videosex国产| 天堂av国产一区二区熟女人妻 | 高清在线国产一区| 国产精品久久久人人做人人爽| 国产v大片淫在线免费观看| 国产男靠女视频免费网站| 操出白浆在线播放| 男人舔女人的私密视频| 亚洲人与动物交配视频| 国产高清视频在线播放一区| 麻豆成人午夜福利视频| 每晚都被弄得嗷嗷叫到高潮| 麻豆成人午夜福利视频| 久久久久久九九精品二区国产 | 97人妻精品一区二区三区麻豆| 精品一区二区三区四区五区乱码| 日韩精品青青久久久久久| 在线观看日韩欧美| 亚洲全国av大片| 一级作爱视频免费观看| 国产高清视频在线播放一区| tocl精华| 人妻夜夜爽99麻豆av| 两性夫妻黄色片| 一区二区三区激情视频| 日韩国内少妇激情av| 久久精品综合一区二区三区| 国产精品野战在线观看| 国产又色又爽无遮挡免费看| 日日干狠狠操夜夜爽| 一区福利在线观看| 久久精品国产亚洲av高清一级| 伦理电影免费视频| 亚洲国产精品sss在线观看| 午夜精品久久久久久毛片777| 欧美不卡视频在线免费观看 | 蜜桃久久精品国产亚洲av| 午夜免费成人在线视频| 欧美在线一区亚洲| 一区二区三区国产精品乱码| 亚洲欧美日韩无卡精品| 丝袜人妻中文字幕| 久久久久国产精品人妻aⅴ院| 国产av不卡久久| √禁漫天堂资源中文www| 日本五十路高清| 久久久国产成人免费| av福利片在线观看| 黄色视频,在线免费观看| 久久午夜综合久久蜜桃| 国产亚洲精品第一综合不卡| 国产成人影院久久av| 女人爽到高潮嗷嗷叫在线视频| 1024香蕉在线观看| 又爽又黄无遮挡网站| 悠悠久久av| 免费人成视频x8x8入口观看| 国产精品野战在线观看| 色噜噜av男人的天堂激情| 国产麻豆成人av免费视频| 亚洲va日本ⅴa欧美va伊人久久| 欧美黑人欧美精品刺激| 精品午夜福利视频在线观看一区| 人妻夜夜爽99麻豆av| 亚洲国产精品成人综合色| 欧美 亚洲 国产 日韩一| 亚洲精品美女久久久久99蜜臀| 免费在线观看黄色视频的| 成人国产综合亚洲| 国产91精品成人一区二区三区| 成熟少妇高潮喷水视频| 麻豆久久精品国产亚洲av| 男女之事视频高清在线观看| 精品欧美一区二区三区在线| 国产野战对白在线观看| 午夜精品在线福利| 一级黄色大片毛片| 性色av乱码一区二区三区2| 看免费av毛片| 午夜福利欧美成人| 国模一区二区三区四区视频 | 国产精品99久久99久久久不卡| 一二三四社区在线视频社区8| 免费在线观看亚洲国产| 两个人的视频大全免费| 日本免费a在线| 日日摸夜夜添夜夜添小说| 少妇被粗大的猛进出69影院| 国产成人aa在线观看| 国产亚洲av高清不卡| 国内毛片毛片毛片毛片毛片| 国产探花在线观看一区二区| 男女午夜视频在线观看| 欧美日韩福利视频一区二区| 亚洲av五月六月丁香网| 久久久精品欧美日韩精品| 91大片在线观看| av国产免费在线观看| a级毛片在线看网站| 激情在线观看视频在线高清| av有码第一页| 天堂影院成人在线观看| 此物有八面人人有两片| 国产成人影院久久av| 又黄又爽又免费观看的视频| 淫秽高清视频在线观看| 怎么达到女性高潮| 香蕉av资源在线| 欧美丝袜亚洲另类 | 人妻久久中文字幕网| 成人av一区二区三区在线看| 精品免费久久久久久久清纯| 国产片内射在线| 久久欧美精品欧美久久欧美| 久久九九热精品免费| 曰老女人黄片| 久久中文字幕人妻熟女| 久久 成人 亚洲| 日韩欧美一区二区三区在线观看| 夜夜夜夜夜久久久久| 日本黄色视频三级网站网址| 51午夜福利影视在线观看| 天堂av国产一区二区熟女人妻 | 午夜激情福利司机影院| 欧美日韩精品网址| 欧美黄色片欧美黄色片| 日本撒尿小便嘘嘘汇集6| 日韩欧美 国产精品| 一个人观看的视频www高清免费观看 | 亚洲性夜色夜夜综合| 九色国产91popny在线| 国产精品香港三级国产av潘金莲| 首页视频小说图片口味搜索| 日韩欧美 国产精品| 制服丝袜大香蕉在线| 亚洲人成网站高清观看| 99re在线观看精品视频| 国产真实乱freesex| 亚洲精品中文字幕在线视频| 色播亚洲综合网| 天天一区二区日本电影三级| 免费看美女性在线毛片视频| 欧美一级a爱片免费观看看 | 日韩有码中文字幕| 亚洲熟女毛片儿| 久久精品国产亚洲av高清一级| 亚洲国产欧美网| 91成年电影在线观看| 欧美一级a爱片免费观看看 | 亚洲欧洲精品一区二区精品久久久| 丁香欧美五月| 免费在线观看亚洲国产| 中文亚洲av片在线观看爽| 国产精品 国内视频| 亚洲欧美日韩东京热| 极品教师在线免费播放| 国产av麻豆久久久久久久| 国产三级黄色录像| 看免费av毛片| 深夜精品福利| 成人三级做爰电影| 亚洲自拍偷在线| 日本撒尿小便嘘嘘汇集6| 黄色成人免费大全| 18禁美女被吸乳视频| 久久精品国产综合久久久| 欧美日韩中文字幕国产精品一区二区三区| 亚洲国产日韩欧美精品在线观看 | 国产午夜福利久久久久久| 香蕉国产在线看| 亚洲精品一卡2卡三卡4卡5卡| 亚洲欧美一区二区三区黑人| 亚洲国产精品合色在线| 国产精品九九99| 两个人看的免费小视频| 99re在线观看精品视频| 久久久久国产一级毛片高清牌| 国产精品久久久av美女十八| 国产69精品久久久久777片 | 亚洲国产精品sss在线观看| 欧美丝袜亚洲另类 | 看免费av毛片| 国产午夜精品久久久久久| 亚洲精品av麻豆狂野| 久久精品影院6| 国产av一区在线观看免费| 午夜福利欧美成人| 国产久久久一区二区三区| av在线播放免费不卡| 99久久综合精品五月天人人| 亚洲精品一区av在线观看| 亚洲欧美激情综合另类| av中文乱码字幕在线| 亚洲欧美激情综合另类| 男女午夜视频在线观看| 精品欧美一区二区三区在线| 亚洲美女视频黄频| 九色国产91popny在线| 国产黄a三级三级三级人| 欧美高清成人免费视频www| 一夜夜www| 三级男女做爰猛烈吃奶摸视频| 两性夫妻黄色片| 身体一侧抽搐| 毛片女人毛片| 久久婷婷成人综合色麻豆| 成人av在线播放网站| 亚洲中文字幕日韩| 青草久久国产| 国产一区二区三区视频了| 香蕉国产在线看| 午夜视频精品福利| 欧美日韩一级在线毛片| 99国产极品粉嫩在线观看| 99精品久久久久人妻精品| 不卡一级毛片| 禁无遮挡网站| 国产午夜福利久久久久久| 在线观看日韩欧美| 国内少妇人妻偷人精品xxx网站 | 欧美乱妇无乱码| 波多野结衣高清无吗| 午夜精品久久久久久毛片777| 妹子高潮喷水视频| 男插女下体视频免费在线播放| 女同久久另类99精品国产91| 久久精品91无色码中文字幕| 中文亚洲av片在线观看爽| 久久九九热精品免费| 欧美一区二区精品小视频在线| 免费在线观看黄色视频的| 2021天堂中文幕一二区在线观| 成年女人毛片免费观看观看9| 午夜a级毛片| 精品久久久久久久久久久久久| 亚洲18禁久久av| 可以在线观看毛片的网站| 欧美性猛交黑人性爽| 黑人操中国人逼视频| 一个人免费在线观看电影 | 全区人妻精品视频| 亚洲色图 男人天堂 中文字幕| 不卡一级毛片| 日本一区二区免费在线视频| 国产三级中文精品| 欧美3d第一页| 一a级毛片在线观看| 国产又黄又爽又无遮挡在线| 深夜精品福利| 中文字幕高清在线视频| 国产精品av久久久久免费| 少妇熟女aⅴ在线视频| 亚洲aⅴ乱码一区二区在线播放 | 亚洲精华国产精华精| 亚洲欧美精品综合一区二区三区| 精品久久久久久久末码| 曰老女人黄片| 99riav亚洲国产免费| 少妇粗大呻吟视频| 狂野欧美白嫩少妇大欣赏| 亚洲精品在线观看二区| 亚洲精品国产一区二区精华液| 精品国产美女av久久久久小说| 亚洲在线自拍视频| 淫秽高清视频在线观看| 不卡av一区二区三区| 欧美zozozo另类| 亚洲精品一卡2卡三卡4卡5卡| 午夜免费激情av| 免费在线观看影片大全网站| 欧美丝袜亚洲另类 | 中文亚洲av片在线观看爽| 久久这里只有精品19| 亚洲国产精品999在线| 亚洲第一欧美日韩一区二区三区| 国产蜜桃级精品一区二区三区| 日韩欧美国产在线观看| 一二三四社区在线视频社区8| 久久久久免费精品人妻一区二区| 成人午夜高清在线视频| 麻豆成人av在线观看| 午夜精品久久久久久毛片777| 午夜免费成人在线视频| 日本在线视频免费播放| 麻豆国产97在线/欧美 | 国产高清激情床上av| 正在播放国产对白刺激| 亚洲熟妇熟女久久| 91九色精品人成在线观看| 国产精品 国内视频| 在线观看www视频免费| 国产成人一区二区三区免费视频网站| 搡老岳熟女国产| 99热这里只有是精品50| av有码第一页| 亚洲专区字幕在线| 亚洲欧美一区二区三区黑人| 三级男女做爰猛烈吃奶摸视频| 免费在线观看黄色视频的| 亚洲自拍偷在线| 日本在线视频免费播放| 亚洲精品国产精品久久久不卡| www日本在线高清视频| www.www免费av|